Thallion Pharmaceuticals Inc.
Profile
Mailing Address: 1375 Autoroute Trans-Canadienne
Bureau 200
Dorval, Québec
H9P 2W8
Head Office Address: 1375 Autoroute Trans-Canadienne
Bureau 200
Dorval, Québec
H9P 2W8
Contact Name: Michael Singer Principal Regulator: Quebec
Business e-mail address: n/a Short Form Prospectus Issuer: No
Telephone Number: 514 940-3600 Reporting Jurisdictions: Ceased Reporting
Fax Number: 514 228-3621 Stock Exchange: N/A
Date of Formation: Jul 22 2009 Stock Symbol:
Jurisdiction Where Formed: Canada Auditor: KPMG
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 88327 Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Nov 30 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents